Evan Stiegel, MD Wins the Tromovitch Award

(June 28, 2019)

QualDerm-affiliated Physician’s Work Mastering Mohs Histopathology Over a 1-year Fellowship Honored at Annual Mohs Meeting

Evan Stiegel, MD, a Fellowship-trained Mohs surgeon, was recently named the winner of the coveted Theodore Tromovitch Award for his work Mastering Mohs Histopathology Over a 1-year Fellowship. Dr. Stiegel practices at Wilson Dermatology Clinic in North Carolina, a QualDerm-affiliated practice.

The Tromovitch Award recognizes the author-presenter of original research performed during the fellowship year of training. The presentation is judged during the American College of Mohs Surgery (ACMS) Annual Meeting. The winner is selected based on the originality of the work, the quality of the science, the relevance to the field of Mohs and reconstructive surgery, and the quality of the oral presentation. This year’s ACMS Annual Meeting was May 2-5 in Baltimore. The award is named after Theodore Tromovitch, MD, who was an internationally-known expert in dermatological surgery.

“One of my goals is to help advance the practice of dermatology,” says Dr. Stiegel. “It is truly an honor for my work to be recognized with this prestigious award.”

During his study, Dr. Stiegel quantified and analyzed the number of cases and amount of time required to achieve a satisfactory level of expertise in the reading and interpretation of Mohs histopathology for a collective group of past fellows at a single MSDO fellowship program. His findings emphasize that a significant amount of time and number of cases required for a fellow to become adept at reading and interpreting Mohs histopathology is quite substantial. The time and number of cases required to reach the acceptable threshold is considerably higher than the minimum number of cases required for a fellowship to be credentialed by the Accreditation Council for Graduate Medical Education, suggesting that their requirements may not be stringent enough.

“We are proud that Dr. Stiegel is part of the QualDerm network,” says Bill Southwick, QualDerm’s Chief Executive Officer. “We strive to partner with the highest-caliber physicians in the specialty and encourage collaboration among our affiliated practices. Physicians and patients across the entire QualDerm network benefit from Dr. Stiegel’s expertise.”

Dr. Stiegel completed a Micrographic Surgery and Cutaneous Oncology Fellowship at Zitelli & Brodland P.C., a Pittsburgh, PA-based Mohs surgery and surgical dermatology practice, which is a QualDerm partnered practice.  He also completed both a medical internship and a dermatology residency at the Cleveland Clinic Foundation in Ohio. Dr. Stiegel served as the Chief Quality Officer of the Cleveland Clinic Department of Dermatology and was co-chair of the Nursing Staff Education Committee for the department. He was recognized as the Gold Medal Award winner at the Cleveland Clinic Department of Dermatology’s 37th Annual Research Day for his work on the prognostic value of sentinel lymph node biopsy according to Breslow thickness for cutaneous melanoma. He has co-authored several publications and lectured nationwide.


About QualDerm Partners

QualDerm Partners helps top-tier dermatologists position their practices for sustainable growth and profitability. The company creates market-leading practice partnerships through affiliations and de novo development. QualDerm provides the management support, capital, and guidance for growth. Under QualDerm’s True PartnershipSM model, physicians are partners, not employees, and retain their own practice brand. This doctor-driven model is designed to maintain physicians’ clinical autonomy and ensure the highest-quality patient care. QualDerm offers physicians tailored partnership structures to meet their needs, as well as the option to sell their practices.  The company has a total of 36 practice locations in North Carolina, South Carolina, Virginia, Tennessee, Ohio, Pennsylvania and Georgia, with plans to expand further. For more information, visit www.QualDerm.com.



Ashley Johnson

SVP, Growth and Operations

QualDerm Partners